Regulation of the Epstein-Barr virus C promoter by AUF1 and the cyclic AMP/protein kinase A signaling pathway

Journal of Virology

Volumn 74, Issue 17, 2000, Pages 8166-8175

  Fuentes Panana, E M ^a   Peng, R ^a   Brewer, G ^a   Tan, J ^a   Ling, P D ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CELL IMMORTALIZATION; CELL PROLIFERATION; CELL STIMULATION; ENHANCER REGION; EPSTEIN BARR VIRUS; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION; TARGET CELL; VIRUS ACTIVATION; VIRUS EXPRESSION; VIRUS RECOMBINANT;

AMINO ACID SEQUENCE; BINDING SITES; CELL LINE; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DNA; DNA-BINDING PROTEINS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRUS 4, HUMAN; HETEROGENEOUS-NUCLEAR RIBONUCLEOPROTEIN D; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN J RECOMBINATION SIGNAL SEQUENCE-BINDING PROTEIN; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; RNA-BINDING PROTEINS; SEQUENCE ANALYSIS, PROTEIN; SIGNAL TRANSDUCTION; TRANS-ACTIVATION (GENETICS); VIRAL PROTEINS;

EID: 0033887512     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.17.8166-8175.2000     Document Type: Article

References (70)

1. A refractory phase in cyclic AMP-responsive transcription requires downregulation of protein kinase A
2. Epstein-Barr virus-induced genes: First lymphocyte-specific G protein-coupled peptide receptors
3. LR1 regulates c-myc transcription in B-cell lymphomas
4. Host factors LR1 and Sp1 regulate the Fp promoter of Epstein-Barr virus
5. RNA binding specificity of hnRNP A1: Significance of hnRNP A1 high-affinity binding sites in pre-mRNA splicing
6. Interactions between the Gs/protein kinase A and the Ras/MAP-kinase signalling pathways
7. Isolation of the heterogeneous nuclear RNA-ribonucleoprotein complex (hnRNP): A unique supramolecular assembly
8. Phosphorylation of human hnRNP protein A1 abrogates in vitro strand annealing activity
9. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation
10. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure
11. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23
12. Activation of latent EBV via anti-IgG-triggered, second messenger pathways in the Burkitt's lymphoma cell line Akata
13. Induction of Epstein-Barr virus lytic cycle by tumor-promoting and non-tumor-promoting phorbol esters requires active protein kinase C
14. AUF1 binding affinity to A+U-rich elements correlates with rapid mRNA degradation
15. A specific isoform of hnRNP D interacts with DNA in the LR1 heterodimer: Canonical RNA binding motifs in a sequence-specific duplex DNA binding protein
16. The cyclic AMP-mediated stimulation of cell proliferation
17. Molecular genetic analysis of Epstein-Barr virus Cp promoter function
18. Epstein-Barr virus-encoded nuclear antigen 2 activates the viral latent membrane protein promoter by modulating the activity of a negative regulatory element
19. Characterization of the CBF2 binding site within the Epstein-Barr virus latency C promoter and its role in modulating EBNA2-mediated transactivation
20. Transcriptional activation signals found in the Epstein-Barr virus (EBV) latency C promoter are conserved in the latency C promoter sequences from baboon and rhesus monkey EBV-like lymphocryptoviruses (cercopithicine herpesviruses 12 and 15)
21. RNA-dependent phosphorylation of a nuclear RNA binding protein
22. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133
23. The determinants of RNA-binding specificity of the heterogeneous nuclear ribonucleoprotein C proteins
24. The Epstein-Barr virus nuclear antigen 2 transactivator is directed to response elements by the J kappa recombination signal binding protein
25. Transcriptional attenuation following cAMP induction requires PP-1-mediated dephosphorylation of CREB
26. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes
27. Nucleolin is one component of the B cell-specific transcription factor and switch region binding protein, LR1
28. Mediation of Epstein-Barr virus EBNA2 transactivation by recombination signal-binding protein J kappa
29. Regulation of in vitro nucleic acid strand annealing activity of heterogeneous nuclear ribonucleoprotein protein A1 by reversible phosphorylation
30. Nuclear proteins that bind the pre-mRNA 3' splice site sequence r(UUAG/G) and the human telomeric DNA sequence d(TTAGGG)(n)
31. Cytoplasmic fate of eukaryotic mRNA: Identification and characterization of AU-binding proteins
32. Three unrelated viral transforming proteins (vIRF, EBNA2, and E1A) induce the MYC oncogene through the interferon-responsive PRF element by using different transcription coadaptors
33. Identification of critical cis elements involved in mediating Epstein-Barr virus nuclear antigen 2-dependent activity of an enhancer located upstream of the viral Bam HI C promoter
34. The proto-oncogene c-myc is a direct target gene of Epstein-Barr virus nuclear antigen 2
35. The UUAG-specific RNA binding protein, heterogeneous nuclear ribonucleoprotein D0: Common modular structure and binding properties of the 2xRBD-Gly family
36. A protein binding to CArG box motifs and to single-stranded DNA functions as a transcriptional repressor
37. Epstein-Barr virus and its replication
38. Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade
39. Identification of two KH domain proteins in the alpha-globin mRNP stability complex
40. The level of c-fgr RNA is increased by EBNA-2, an Epstein-Barr virus gene required for B-cell immortalization
41. Transient CRE- and kappa B site-binding is cross-regulated by cAMP-dependent protein kinase and a protein phosphatase in mouse splenocytes
42. TPA induction of Epstein-Barr virus early antigens in Raji cells is blocked by selective protein kinase-C inhibitors
43. Inhibition of antigen processing by the internal repeat region of the Epstein-Barr virus nuclear antigen-1
44. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancer-binding protein
45. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif
46. Both isoforms of the cAMP-dependent protein kinase catalytic subunit can activate transcription of the prolactin gene
47. Crucial sequences within the Epstein-Barr virus TP1 promoter for EBNA2-mediated transactivation and interaction of EBNA2 with its responsive element
48. Duplicated CArG box domains have positive and mutually dependent regulatory roles in expression of the human alpha-cardiac actin gene
49. Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell
50. A novel form of Epstein-Barr virus latency in normal B cells in vivo
51. Regulation of the mRNA-binding protein AUF1 by activation of the beta-adrenergic receptor signal transduction pathway
52. Immunopurification of heterogeneous nuclear ribonucleoprotein particles reveals an assortment of RNA-binding proteins
53. Epstein-Barr virus
54. An ATF/CRE element mediates both EBNA2-dependent and EBNA2-independent activation of the Epstein-Barr virus LMP1 gene promoter
55. Cloning and characterisation of a nuclear, site specific ssDNA binding protein
56. EBNA-2 transactivates a lymphoid-specific enhancer in the BamHI C promoter of Epstein-Barr virus
57. Identification and cloning of a novel heterogeneous nuclear ribonucleoprotein C-like protein that functions as a transcriptional activator of the hepatitis B virus enhancer II
58. Epstein-Barr virus and the B cell: That's all it takes
59. Transcriptional regulation of the complement receptor 2 gene: Role of a heterogeneous nuclear ribonucleoprotein
60. Heterogeneous nuclear ribonucleoprotein D0B is a sequence-specific DNA-binding protein
61. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23
62. Epstein-Barr virus nuclear antigen 2 specifically induces expression of the B-cell activation antigen CD23
63. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1
64. The search for trans-acting factors controlling messenger RNA decay
65. Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection
66. Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV
67. B-cell lines immortalized with an Epstein-Barr virus mutant lacking the Cp EBNA2 enhancer are biased toward utilization of the oriP-proximal EBNA gene promoter Wp1
68. Purification, characterization, and cDNA cloning of an AU-rich element RNA-binding protein, AUF1
69. The Epstein-Barr virus nuclear antigen 2 interacts with an EBNA2 responsive cis-element of the terminal protein 1 gene promoter
70. Persisting oncogenic herpesvirus induced by the tumour promoter TPA